|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Oct―16 |
Characterization of the symmetrical benzimidazole twin drug TL1228: the role as viral entry inhibitor for fighting COVID-19 |
Michela Murdocca, Osvaldo Andrade Santos-Filho, Claudia De Masi, Edivaldo dos Santos Rodrigues, Claudia Valeria Campos de Souza, Riccardo De Santis, et al. (+13) Donatella Amatore, Andrea Latini, Rossella Schipani, Lino di Rienzo Businco, Bruno Brandimarte, Giorgia Grilli, Tien L Huang, Annie S Mayence, Florigio Lista, Andrea Duranti, Federica Sangiuolo, Jean Jacques Vanden Eynde, Giuseppe Novelli |
2 |
[GO] |
2023―Sep―05 |
Total network controllability analysis discovers explainable drugs for Covid-19 treatment |
Xinru Wei, Chunyu Pan, Xizhe Zhang, Weixiong Zhang |
3 |
[GO] |
2022―Jun―05 |
Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y |
Yichao Zhu, Wenzhao Zhou, Zubiao Niu, Jiayi Sun, Zhengrong Zhang, Qinqin Li, et al. (+4) You Zheng, Chenxi Wang, Lihua Gao, Qiang Sun |
4 |
[GO] |
2021―Oct―21 |
Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection |
He Ren, Chaobing Ma, Haoran Peng, Bo Zhang, Lulin Zhou, Yan Su, et al. (+2) Xiaoyan Gao, Hongyan Huang |
5 |
[GO] |
2020―Dec―29 |
The immune system view of the coronavirus SARS-CoV-2 |
Ivana Celardo, Luigia Pace, Loredana Cifaldi, Carlo Gaudio, Vincenzo Barnaba |
6 |
[GO] |
2020―Nov―27 |
Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? |
Alexei Verkhratsky, Qing Li, Sonia Melino, Gerry Melino, Yufang Shi |
7 |
[GO] |
2020―Nov―02 |
Serological determinants of COVID-19 |
Annalisa Noce, Maria Luisa Santoro, Giulia Marrone, Cartesio D’Agostini, Ivano Amelio, Andrea Duggento, et al. (+2) Manfredi Tesauro, Nicola Di Daniele |
8 |
[GO] |
2020―Oct―16 |
COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein |
Sepehr Ehsani |